FOXP3 and neoplasm: Chawla et al. found that moderate to marked lymphocyte infiltrates were present in 58.8% of the HNC patient cohort, including T cells, B cells, and FoxP3-expressing T cells, while Gal-1 staining within lymphocyte areas of the tumor was significantly associated with poorer patient outcomes [45].